A biotech focused on improving the profiles of generic medicines through its proprietary transdermal delivery technology. The platform technology uniquely combines high flux and sustained release into a matrix drug in adhesive patch. ChemioCare has 3 patches in development for cancer and cancer supportive care.
| Website | http://www.chemio.care |
| Employees | 7 (7 on RocketReach) |
| Founded | 2017 |
| Phone | +1 800-449-5405 |
| Industry | Biotechnology, Pharmaceuticals, Computer Software, Pharmaceutical, Health Care, Broadcast Media, Investment Management |
| Keywords | New Drug Delivery, Transdermal Drug Delivery, Proprietary Technology, Pharmaceutical Development, Transdermal Patches, Drug Delivery Systems, Controlled Release Technology, Generic Medicines, Biotechnology, Pharmaceutical Research, Drug Delivery Research, Medical Technology |
| Competitors | Carevīve, OncoOne, Medidata Solutions, NantHealth, Teladoc Health, Flatiron Health, Cureatr, Clara Health (acquired by M&B Sciences), ZyDoc, CureMetrix +30 more (view full list) |
Looking for a particular ChemioCare Inc employee's phone or email?
Pedro Lichtinger is the Chairman and CEO of ChemioCare Inc.
7 people are employed at ChemioCare Inc.